Skip to content

Rheumatoid Foot Insole

Effect of Rheumatoid Foot Insole

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01546610
Enrollment
80
Registered
2012-03-07
Start date
2011-11-30
Completion date
2012-11-30
Last updated
2012-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

Rheumatoid foot, foot pain, insoles, foot function, electronic baropodometer, plantar pressure, gait analysis

Brief summary

The present study aims to evaluate the effect of insoles for foot arthritis.

Detailed description

A randomized, controlled, double-blind, prospective trial being conducted involving 80 patients with rheumatoid arthritis, according to American College of Rheumatology (ACR) criteria, and foot pain, selected from outpatient clinics - Federal University of Sao Paulo (UNIFESP). Patients will be randomized in to two groups: experimental (40) and control (40). The experimental group will use ethyl-vinyl acetate (EVA) foot orthoses, with support retrocapital and support of medial arch (insole intervention). The control group will use the same material flat insole (insole placebo).

Interventions

OTHERinsoles intervention

EVA insole with arch support and bar retrocapital

EVA insole flat

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with established diagnosis RA according to criteria of the American College of Rheumatology (ACR) functional classes I, II and III * Foot pain with VAS between 3 - 8 cm for walking * Age 18-65 years * Basic medication stable for at least three months * Not made infiltrations in feet and ankles in the last three months and not during the study * Agreed to participate and signed term of informed consent

Exclusion criteria

* Other musculoskeletal disorders in symptomatic lower limbs * Diseases of the central and peripheral nervous system * Decompensated diabetes mellitus * No walking * Rigid deformities in the feet * Use of insoles in the last three months * Surgery scheduled in the next 12 months * Allergy to the material * Mental deficiency

Design outcomes

Primary

MeasureTime frameDescription
Visual analog scale of pain in feet during walking (VAS)12 monthsAssessing pain in the feet during walking through a visual analog scale from 0 to 10 centimeter (cm)

Secondary

MeasureTime frameDescription
Health Assessmente Questionnaire (HAQ)12 monthsFunctional capacity assessed by HAQ in rheumatoid arthritis
Foot Function Index (FFI)12 monthsFunction of the foot
Visual analog scale of pain in feet at rest (VAS)12 monthsAssessing pain in the feet at rest through a visual analog scale from 0 to 10
6-MINUTE WALK TEST12 monthsAssess functional capacity
Foot Health Status Questionnaire (FHSQ-Br)12 monthsFoot Health Status
LIKERT SCALE12 monthsLikert scale by patients
TESTS BAROPODOMETRIC12 monthsEvaluates charge distribution in the feet and gait variables
TIME USE OF INSOLE12 monthsControl the use of time insole
Shorth Form-36 (SF-36)12 monthsQuality of life by SF-36

Countries

Brazil

Contacts

Primary ContactEmilia Moreira
emilia.moreira@hotmail.com551125942014
Backup ContactJamil MD Natour, PHD
jnatour@unifesp.br551155764239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026